Chromatin immunoprecipitation demonstrated that the ELK-1 transcription factor binds to the pdgf-b promoter in response to SDF-1α. We confirmed the correlation between the SDF-1α/PDGF-B pathway and the differentiation of PDGFR-β+ BMCs into mature pericytes using an in vitro assay. These findings demonstrate that SDF-1α regulates PDGF-B expression and that this regulation plays a critical role in the differentiation of PDGFR-β+ BMCs into mature pericytes.
Introduction
Platelet derived growth factor B (PDGF-B) is a member of the PDGF family of growth factors.
When synthesized and secreted in its homodimer form, PDGF-BB binds to its tyrosine kinase receptor, PDGFR-β . Mature pericytes play a role in vascular stabilization, maturation, and survival and surround endothelial cells, which together form the basement membrane of the microvessels 6 . Mature pericytes contribute to efficient vascular flow and prevent vascular leakage 3 . As PDGF-B plays a critical role in the differentiation process for pericytes, understanding the pathways that regulate PDGF-B in the tumor microenvironment will enable the identification and development of agents that interfere with pericyte maturation which results in vascular reduction during tumor vascular development 7 . Several studies have shown that targeting pericytes in addition to endothelial cells is more effective at inhibiting tumor growth than targeting one or the other alone 8, 9 . PDGF-B expression can be regulated by several mechanisms, including transcriptional vector containing the stromal-derived factor gene (Ad-SDF-1α) increased PDGF-B mRNA levels, increased infiltration and differentiation of bone marrow cells (BMCs) into pericytes, and rescued tumor growth 11, 12 . The purpose of the current study was to investigate the mechanism by which SDF-1α induced the expression of PDGF-B and examine the role of the SDF-1α/PDGF-B pathway in the differentiation of BMCs into pericytes.
SDF-1α or CXCL12 is an alpha chemokine that binds to the 7-transmembrane G-protein coupled receptor CXCR4 13, 14 . Signaling through the SDF-1α/CXCR4 pathway initiates multiple downstream signaling pathways linked to transcription and expression through MEK1/2 and ERK1/2. ERK can phosphorylate and activate other cellular proteins as well as translocate to the nucleus and phosphorylate and /or activate transcription factors 13 . The binding of SDF-1α to CXCR4 induces phosphorylation of the mitogen-activated protein kinases (MAPKs) p44 ERK-1 and p42 ERK-2, which subsequently initiates the phosphorylation of the nuclear transcription factor ELK-1 15 . The ELK-1 nuclear transcription factor is a member of the 3 ternary complex factors (TCFs), a subfamily of the ETS-domain transcription factors. TCFs are involved in several biological processes; members of this family have been shown to be important in regulating angiogenesis and vasculogenesis [16] [17] [18] [19] [20] . We demonstrate here for the first time that SDF-1α regulates the expression of PDGF-B and that this regulation involves binding of the ELK-1 transcription factor to the pdgf-b promoter. Our data also showed that the SDF-1α/PDGF-B pathway plays a critical role in the differentiation of PDGFR-β+ BMCs into desmin and NG2 expressing mature pericytes. 
Proteins and antibodies
Recombinant human SDF-1α was purchased from R&D Systems 
PDGF-B immunohistochemical analysis and microscopy
To investigate the effect of SDF-1α on PDGF-B protein levels in vivo, tumor sections obtained directions. At 48 hours after transfection, the medium was replaced with fresh DMEM and the cells were cultured under puromycin selection (2 μg/mL) (InvivoGen, San Diego, CA). RNA was isolated using the TRIzol method, and cDNA was synthesized using a reverse-transcription system (Promega). Down-regulation of SDF-1α was confirmed by q-PCR using primers for mouse SDF-1α. Mouse SDF-1α primers were designed and synthesized using SigmaGenosys.com (Sigma-Genosys, Spring, TX). All sequences are available upon request.
pdgf-b promoter cloning
DNA was isolated from TC71 Ewing's sarcoma cells. The 2-kb pdgf-b promoter DNA fragment was isolated by PCR. Briefly, primers were designed and synthesized using Integrated DNA Technologies (IDT). All sequences are available upon request. The PCR product was run on a 1% agarose gel, and the 2-kb pdgf-b promoter DNA fragment was isolated and purified using the 
Dual-luciferase reporter assay
We used 50 ng of either the pdgf-b/pGL3 reporter construct or the pGL3-Control vector (Promega BioSciences; E1761) to transfect TC/siVEGF 7-1 and HEK293 cells using FuGENE 6 (Roche Applied Science) according to the manufacturer's directions. Beginning 48 hours after transfection, the cells were cultured in the absence of growth factors and supplements for 24hours and then treated with 100 ng/mL of either the recombinant SDF-1α or the inactive 9SDF-1α protein for 8hours. The cells were lysed and the luciferase signal measured using the Dual-Luciferase Reporter Assay System (Promega BioSciences; E1910) according to the manufacturer's instructions.
ChIP assay
Potential ELK-1 binding sites within the 2-kb pdgf-b promoter region were identified using the Primers were synthesized using Sigma-Genosys.com. All sequences are available upon request.
The data was analyzed using the STATISTICA 6.0 software. The sample values minus the control values were used in one-way analysis of variance, with post hoc analysis using the Fisher least significant difference to determine significant differences. The graph represents data pooled from 3 independent trials +/-SD and is scaled from 0 to 1 with 0 representing no binding and 1 representing complete binding of ELK-1 to the promoter region of interest. P values < 0.05 were considered statistically significant.
In vitro pericyte differentiation model
Whole BMCs were isolated from nude mice by flushing their hind femurs with sterile PBS.
Fresh BMCs were analyzed for PDGFR-β, desmin, and NG2 expression. Briefly, the cells were collected and then cytospun onto glass slides by centrifuging at 30 rpm for 2mins at RT in the 
Immunocytochemistry staining
BMCs were collected and cultured as described above. The cells were fixed in cold acetone and blocked with 4% fish gelatin in PBS as previously described 
Results

SDF-1α regulates the expression of PDGF-B in vitro and in vivo
We previously showed that intratumor injections of an adenoviral vector containing SDF-1α (Ad-SDF-1α) into VEGF 165 
SDF-1α regulates the expression of PDGF-B via transcription
We next investigated whether SDF-1α regulates PDGF-B through a transcriptional mechanism.
We cloned the 2-kb human pdgf-b promoter fragment into a luciferase reporter vector. DNA was collected from TC71 cells and used as a template to isolate the 2-kb promoter fragment. The purified fragment was cloned into the PGL3 reporter vector, and the luciferase signal was 
minutes, and ChIP was performed. The ELK-1 transcription factor bound to the pdgf-b promoter with a peak binding at 30 minutes (P < 0.05) and with a higher affinity at the -600 bp site ( Figure   5B ) than at the TS site (P > 0.05; data not shown). To determine whether SDF-1α in the 10T1/2 conditioned medium played a role in inducing PDGFR-β+ BMCs to express NG2 and desmin, we cultured PDGFR-β+ BMCs in conditioned medium from 10T1/2-shSDF-1 or 10T1/2-shcontrol cells for 2 weeks. We already showed that transfection of 10T1/2 cells with shSDF-1 decreased PDGF-B expression (Figure 3) . PDGFR-β+ BMCs cultured in 10T1/2-shSDF-1 conditioned medium behaved in a similar manner to those cultured in DMEM alone: their morphology did not change, and they failed to express NG2 and desmin ( Figure 7A ). In contrast, PDGFR-β+ BMCs cultured in 10T1/2-shcontrol conditioned medium stained positive for desmin, and NG2 and had a similar pericyte-like morphology to those cultured in conditioned medium from 10T1/2 cells ( Figure 7B ). These results confirm that 
PDGFR-β+
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Discussion
The regulation of PDGF-B expression during vascular remodeling is poorly understood. We previously demonstrated that the inhibition of VEGF 165 The ELK-1 transcription factor is a member of the 3 ternary complex factors (TCFs) which is a subfamily of the E twenty-six (Ets) domain transcription factors 19 . SDF-1α binds to the 7-transmembrane G-protein coupled receptor CXCR4 and induces phosphorylation of the MAPKs p44 ERK-1 and p42 ERK-2, which further leads to the phosphorylation of the nuclear transcription factor ELK-1 [13] [14] [15] . We identified potential ELK-1 binding sites within the pdgf-b promoter region and found that SDF-1α stimulates binding of ELK-1 to the pdgf-b promoter at the -600 bp site in both TC/siVEGF 7-1 and HEK293 cells. We are the first to report the regulation 
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